Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice
Authors:
- 1 November 2016
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 791, 735-740
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81370872)
This publication has 31 references indexed in Scilit:
- Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shockCell Research, 2013
- Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Sensing and reacting to microbes through the inflammasomesNature Immunology, 2012
- Pharmacotherapy for Prevention and Treatment of Acute Respiratory Distress SyndromeDrugs, 2010
- The InflammasomesCell, 2010
- Animal models of acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Anti-proliferative effect of pro-inflammatory cytokines in cultured β cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1Journal of Molecular Endocrinology, 2008
- Interleukin-1β Causes Acute Lung Injury via αvβ5 and αvβ6 Integrin–Dependent MechanismsCirculation Research, 2008
- Reconstituted NALP1 Inflammasome Reveals Two-Step Mechanism of Caspase-1 ActivationMolecular Cell, 2007
- NALPs: a novel protein family involved in inflammationNature Reviews Molecular Cell Biology, 2003